Metabolic Alterations, Vascular Disease and Advanced Prostate Cancer: New Players for Metastatic Advanced Prostate Cancer?
Pages 33-35
Simona Di Francesco and Raffaele L. Tenaglia
DOI: http://dx.doi.org/10.6000/1927-7229.2014.03.01.5
Published: 31 January 2014

Abstract: Introduction: Epidemiologic studies have implicated metabolic imbalance in prostate cancer (PCa) aggressiveness, nevertheless no clear consensus has been reached. The aim of the research was to investigate the association of hypertension, hypercholesterolemia and vascular disease in advanced PCa with and without bone metastases.

Methods: Retrospective analysis of 66 patients with diagnosis of advanced PCa between 2005 and 2009 was conducted. We examined hypertension, hypercholesterolemia and vascular disease in 25 patients with advanced PCa and bone metastases versus 41 patients with advanced non-metastatic PCa. Men with incomplete data available, history of hormone therapy or chemotherapy, vascular surgery or other anticancer therapies were excluded.

Results:Hypertensionwas significantly linked to advanced PCa with bone metastases (OR 4.5, p = 0.01). Hypercholesterolemia also was significantly associated with aggressive metastatic PCa (OR 3.28, p = 0.01). A significant association was noted between metastatic PCa and vascular disease (OR 3.8, p = 0.04).

Conclusions:In our study,hypertension, hypercholesterolemia and vascular disease were significantly related to advanced metastatic PCa. Further research should elucidate these relations in larger samples to confirm these associations and to stabilize future prevention strategies.